ESC Professional Premium Access

The comparison of short-term dual antiplatelet therapy versus standard dual antiplatelet therapy in elderly patients with coronary artery disease who underwent percutaneous coronary intervention

Congress Presentation

About the speaker

Doctor In Tae Jin

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))
0 follower

7 more presentations in this session

Comparative discontinuation and non-bleeding side effects of Clopidogrel, Prasugrel and Ticagrelor in patients with acute coronary syndromes; a Network Meta-analysis of Randomized Controlled Trials

Speaker: Doctor S. Yanko (Jerusalem, IL)

Thumbnail

Anticoagulant monotherapy versus anticoagulant therapy in combination with single antiplatelet agent in patients after coronary artery bypass grafting - analysis of real-world data

Speaker: Associate Professor R. Dabrowski (Warsaw, PL)

Thumbnail

Impact of procedural and patient-related risks on 1-year outcomes for patients with 1-month DAPT followed by P2Y12 inhibitor monotherapy after biodegradable-polymer drug-eluting stent implantation

Speaker: Doctor R. Shimada (Yahaba, JP)

Thumbnail

Clinical outcomes of risk score-guided dual antiplatelet therapy in patients with acute coronary syndrome who underwent percutaneous coronary intervention

Speaker: Assistant Professor D. Hyun (Kwang Ju, KR)

Thumbnail

Elderly patients are hyperresponsive to potent P2Y12 inhibitors

Speaker: Doctor D. Mutschlechner (Mistelbach, AT)

Thumbnail

Access the full session

Data-driven decisions for anticoagulant and antiplatelet therapy

Speakers: Doctor I. Jin, Doctor S. Yanko, Associate Professor R. Dabrowski, Doctor R. Shimada, Assistant Professor D. Hyun...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations